Relationship between the polymorphism of tumor necrosis factor-α-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: A meta-analysis

European Journal of Human Genetics

Volumn 19, Issue 4, 2011, Pages 432-437

  Fan, Wang ^a   Maoqing, Wang ^a   Wangyang, Chen ^a   Fulan, Hu ^a   Dandan, Li ^a   Jiaojiao, Ren ^a   Xinshu, Dong ^a   Binbin, Cui ^a   Yashuang, Zhao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

colorectal cancer; Crohn's disease; inflammatory bowel disease; tumor necrosis factor ; ulcerative colitis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER RISK; COLORECTAL CANCER; CROHN DISEASE; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

ASIAN CONTINENTAL ANCESTRY GROUP; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; CROHN DISEASE; CYTOKINES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952767116     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.159     Document Type: Article

References (42)

1. Edwards CN, Griffith SG, Hennis AJ, Hambleton IR: Inflammatory bowel disease: incidence, prevalence, and disease characteristics in Barbados, West Indies. Inflamm Bowel Dis 2008; 14: 1419-1424
2. Kraus S, Arber N: Inflammation and colorectal cancer. Curr Opin Pharmacol 2009; 9: 405-410
3. Triantafillidis JK, Nasioulas G, Kosmidis PA: Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 2009; 29: 2727-2737
4. Sun X-w, Wu S-l, Lin Y-j, Bo W, Han H-l, Dai X-d: Trend of morbidity and mortality of colorectal carcinom a in Nangang District of Harbin from 1992 to 2001. World Chin J Digestol 2004; 12: 2302-2306 (Pubitemid 40138465)
5. Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF: A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 2006; 101: 993-1002 (Pubitemid 43725312)
6. El-Tawil AM: A population-based case-control study of potential risk factors for IBD. Am J Gastroenterol 2009; 104: 1064
7. Kim TH, Kim BG, Shin HD et al: [Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease]. Korean J Gastroenterol 2003; 42: 377-386
8. Fidder HH, Heijmans R, Chowers Y et al: TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease. Int J Immunogenet 2006; 33: 81-85
9. Llanos C, Soto L, Sabugo F et al: [The influence of-238 and-308 TNF alpha polymorphisms on the pathogenesis and response to treatment in rheumatoid arthritis]. Rev Med Chil 2005; 133: 1089-1095
10. Mossbock G, Renner W, El-Shabrawi Y et al: TNF-alpha-308 G4A and-238 G4A polymorphisms are not major risk factors in Caucasian patients with exfoliation glaucoma. Mol Vis 2009; 15: 518-522
11. Flego V, Radojcic Badovinac A, Bulat-Kardum L et al: Primary lung cancer and TNF-alpha gene polymorphisms: a case-control study in a Croatian population. Med Sci Monit 2009; 15: CR361-CR365
12. Yang JJ, Ko KP, Cho LY et al: The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study. BMC Cancer 2009; 9: 238
13. Kohaar I, Tiwari P, Kumar R et al: Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population. Breast Cancer Res Treat 2009; 114: 347-355
14. Bouma G, Xia B, Crusius JB et al: Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1996; 103: 391-396 (Pubitemid 26089943)
15. Sashio H, Tamura K, Ito R et al: Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics 2002; 53: 1020-1027 (Pubitemid 34275765)
16. Martin K, Radlmayr M, Borchers R, Heinzlmann M, Folwaczny C: Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 2002; 66: 121-126 (Pubitemid 35356692)
17. Gonzalez S, Rodrigo L, Martinez-Borra J et al: TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol 2003; 98: 1101-1106 (Pubitemid 36733773)
18. Vatay A, Bene L, Kovacs A et al: Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics 2003; 55: 247-252 (Pubitemid 36960518)
19. Balding J, Livingstone WJ, Conroy J et al: Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm 2004; 13: 181-187 (Pubitemid 39093340)
20. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcon G, Rodriguez-Perez JM, Zuniga J, Granados J: Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis. Immunol Lett 2004; 95: 31-35 (Pubitemid 39119897)
21. Fowler EV, Eri R, Hume G et al: TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J Med Genet 2005; 42: 523-528 (Pubitemid 40847244)
22. Cantor MJ, Nickerson P, Bernstein CN: The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 2005; 100: 1134-1142 (Pubitemid 40769053)
23. Song Y, Wu KC, Zhang L et al: Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease. Chin J Dig Dis 2005; 6: 170-174
24. Ferreira AC, Almeida S, Tavares M et al: NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease. Inflamm Bowel Dis 2005; 11: 331-339 (Pubitemid 40542264)
25. Zipperlen K, Peddle L, Melay B, Hefferton D, Rahman P: Association of TNF-alpha polymorphisms in Crohn disease. Hum Immunol 2005; 66: 56-59 (Pubitemid 40037711)
26. Castro-Santos P, Suarez A, Lopez-Rivas L, Mozo L, Gutierrez C: TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Am J Gastroenterol 2006; 101: 1039-1047 (Pubitemid 43725318)
27. Yang SK, Lee SG, Cho YK, Lim J, Lee I, Song K: Association of TNF-alpha/LTA polymorphisms with Crohn's disease in Koreans. Cytokine 2006; 35: 13-20 (Pubitemid 44485530)
28. Sykora J, Subrt I, Didek P et al: Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position-308 G-4A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 2006; 42: 479-487
29. Qian C, Qin Z, Minliang W, Weiling H, Min G, Jianmin S: Genetic susceptibility to ulcerative colitis in the Chinese Han ethnic population: association with TNF polymorphisms. Chin Med J 2006; 14: 1198-1203
30. Celik Y, Dagli U, Kilic MY et al: Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand J Gastroenterol 2006; 41: 559-565
31. Cucchiara S, Latiano A, Palmieri O et al: Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007; 44: 171-179 (Pubitemid 46175068)
32. Mittal RD, Manchanda PK, Bid HK, Ghoshal UC: Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India. J Gastroenterol Hepatol 2007; 22: 920-924 (Pubitemid 46911018)
33. Ferguson LR, Huebner C, Petermann I et al: Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroenterol 2008; 14: 4652-4661
34. Jang WH, Yang YI, Yea SS et al: The-238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 2001; 166: 41-46
35. Landi S, Moreno V, Gioia-Patricola L et al: Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 2003; 63: 3560-3566 (Pubitemid 36793036)
36. Macarthur M, Sharp L, Hold GL, Little J, El-Omar EM: The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol Biomarkers Prev 2005; 14: 1613-1618 (Pubitemid 40995069)
37. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N: Inflammationrelated gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 1126-1131
38. Theodoropoulos G, Papaconstantinou I, Felekouras E et al: Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol 2006; 12: 5037-5043 (Pubitemid 44323275)
39. Toth EK, Kocsis J, Madaras B et al: The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. Int J Cancer 2007; 121: 1744-1748 (Pubitemid 47417292)
40. Garrity-Park MM, Loftus Jr EV, Bryant SC, Sandborn WJ, Smyrk TC: Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer. Am J Gastroenterol 2008; 103: 407-415 (Pubitemid 351248709)
41. Heuschen UA, Hinz U, Allemeyer EH et al: Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 2001; 120: 841-847 (Pubitemid 32193181)
42. Bouma G, Crusius JB, Garcia-Gonzalez MA et al: Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol 1999; 115: 294-300. (Pubitemid 29052456)